SST® (Site-Specific Targeting)
Specially formulated with SST® technology to deliver a combination of caraway oil and l-Menthol, the primary component of peppermint oil, quickly and reliably to help normalize the digestive and absorptive processes that have been disrupted by FD.
“What I like about FDgard® is it’s very safe, very easy to access...It’s very effective, and I find that it works early on.”
“FDgard® [has] very minimal side effects and is easily accessible over the counter.”
“One will do anything to feel better, so my husband and I went to CVS/pharmacy and luckily found one remaining box on the shelf, I bought it, took it that afternoon and again the next morning. To my surprise and amazement, I felt great within a short time, and continued feeling wonderful.”
1 Nguyen, Nam Q., and Rupert W L Leong. 2008. “Current Application of Confocal Endomicroscopy in Gastrointestinal Disorders.” Journal of Gastroenterology and Hepatology (Australia) 23 (10): 1483–91. doi:10.1111/j.1440-1746.2008.05469.x.
2 Ji, Rui, Tao Yu, Xiao Meng Gu, Xiu Li Zuo, Kun An, Cheng Jun Zhou, and Yan Qing Li. 2011. “Gastric Metaplasia of the Duodenum: In Vivo Diagnosis by Endomicroscopy and Its Relationship with Functional Dyspepsia.” Journal of Gastroenterology and Hepatology (Australia) 26 (1): 73–77. doi:10.1111/j.1440-1746.2010.06479.x.
3 Vanheel, Hanne, Maria Vicario, Tim Vanuytsel, Lukas Van Oudenhove, Cristina Martinez, Åsa V Keita, Nicolas Pardon, et al. 2014. “Impaired Duodenal Mucosal Integrity and Low-Grade Inflammation in Functional Dyspepsia.” Gut 63 (2): 262–71. doi:10.1136/gutjnl-2012-303857.
4 Yantiss, Rhonda K, and Robert D Odze. 2009. “Optimal Approach to Obtaining Mucosal Biopsies for Assessment of Inflammatory Disorders of the Gastrointestinal Tract.” The American Journal of Gastroenterology 104 (3): 774–83. doi:10.1038/ajg.2008.108.
5 Lelyveld, N. Van, J. T. Linde, M. Schipper, and M. Samsom. 2008. “Candidate Genotypes Associated with Functional Dyspepsia.” Neurogastroenterology and Motility 20 (7): 767–73. doi:10.1111/j.1365-2982.2008.01102.x.
6 Trimble, K C, R Farouk, A Pryde, S Douglas, and R C Heading. 1995. “Heightened Visceral Sensation in Functional Gastrointestinal Disease Is Not Site-Specific.” Digestive Diseases and Sciences 40 (8). Springer: 1607–13.
7Stanghellini, V, C Ghidini, M R Maccarini, G F Paparo, R Corinaldesi, and L Barbara. 1992. “Fasting and Postprandial Gastrointestinal Motility in Ulcer and Non-Ulcer Dyspepsia.” Gut 33 (2): 184–90. https://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1373927&tool=pmcentrez&rendertype=abstract.
8 Bassotti, Gabrio, Maria Antonietta Pelli, and Antonio Morelli. 1990. “Duodenojejunal Motor Activity in Patients with Chronic Dyspeptic Symptoms.” Journal of Clinical Gastroenterology 12 (1). LWW: 17–21.
9 Groschwitz, Katherine R, and Simon P Hogan. 2009. “Intestinal Barrier Function: Molecular Regulation and Disease Pathogenesis.” The Journal of Allergy and Clinical Immunology 124 (1): 3-20-2. doi:10.1016/j.jaci.2009.05.038.
10 Castillo EJ, Camilleri M, Locke GR, et al. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol. 2004;2(11):985-996. doi:10.1016/S1542-3565(04)00454-9
11 Thompson Coon, J, and E Ernst. 2002. “Systematic Review: Herbal Medicinal Products for Non-Ulcer Dyspepsia.” Alimentary Pharmacology & Therapeutics 16 (10): 1689–99. doi:10.1046/j.0269-2813.2002.01339.x.
12 Chey WD, Lacy BE, Cash BD, Epstein M, et al. A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial. Clin Transl Gastroenterol. 2019;10(4) (FDRESTTM, Functional Dyspepsia Response Evaluation and Safety Trial)
13 FDACTTM, Functional Dyspepsia Adherence and Compliance Trial, a peer-reviewed and presented patient-reported outcomes study by Dr. Chey (ACG 2017).